＊ Network with top executives, investors, experts and renown leaders from Taiwan, China, and beyond
＊ Exhibit bioclusters, technologies, unique products and services
＊ Discover biopharma innovations in Taiwan and Asia
＊ Capture Greater China and Asia’s biotech market opportunities through Taiwan
＊ Explore R&D, products, services and new partnerships
Taiwan’s biotech industry market value has reached 900bil TWD (30bil USD) and will soon approach its first trillion TWD as Taiwan becomes an integral part of the global biopharma industry chain. The government’s initiatives to support Taiwan's biotech development and innovation are critical for continued strong growth momentum. BioBuisness Asia explores such investment opportunities in Taiwan. The event takes an in-depth look at issues regarding bio-investing and future trends in biomedical and life sciences within the Asia region. In 2016, the BioTaiwan exhibition had a record number of participants, reaching a total of 605 exhibitors, 1,305 booths, and 100,786 plus visitors representing Taiwan, Japan, Korea, China, India, North America and countries from the European Union.